GLP-1 receptor agonists bind to and activate GLP-1 receptors located throughout the body, particularly in pancreatic beta cells, the gastrointestinal tract, and the central nervous system
Zhou J, Livak MF, Bernier M, Muller DC, Carlson OD, Elahi D, Maudsley S, Egan JM (2007) Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets
Wegovy is also the only weight loss injection approved to reduce the risk of major cardiovascular events , with trials showing a 20% reduction in events in overweight or obese adults
Approach to the Patient With Thyroid Nodules: Considering GLP-1 Receptor Agonists
Novo Nordisk has the advantage of building the first large-scale semaglutide franchise
This article explores how GLP-1 works, how your genes influence GLP-1 levels, and how your genes interact with your response to GLP-1 RA medications for weight loss or diabetes